Net sales

2,319

2,145

8%

Gross profit

636

591

8%

Gross profit as a percentage of net sales

27.4%

27.6%

–

Research & development expenses

–105

–97

8%

R&D expenses as a percentage of net sales

4.5%

4.5%

–

Selling, general and administration expenses⁴

–325

–308

6%

SG&A expenses as a percentage of net sales

14.0%

14.4%

–

Operating profit (EBIT)

206

186

11%

Goodwill amortization

0

0

–

EBITA (Glossary) ⁵

206

186

11%

EBITA as a percentage of net sales (EBITA margin)

8.9%

8.7%

–

Amortization/depreciation of property, plant and equipment and licenses and write-down of reworkable service parts

54

47

15%

EBITDA (Glossary) 

260

233

12%

EBITDA as a percentage of net sales (EBITDA margin)

11.2%

10.9%

–

Profit for the period (Glossary) 

127

109

17%

Profit for the period as a percentage of net sales

5.5%

5.1%

–

Profit for the period before carve-out (Glossary) 

135

118

14%

Earnings per share (€)⁶

4.08

3.54

–

Cash flow (€ million)

Cash flow from operating activities

196

180

9%

Cash flow from investment activities

–72

–66

9%

Sept. 30, 2008

Sept. 30, 2007

Change

Key Balance Sheet Figures
(€ million)

Working capital (Glossary) ⁷

253

255

–2

as a percentage of net sales

10.9%

11.9%

–

Net debt (Glossary) 

194

182

12

Equity⁸

276

278

–2

Human Resources

Number of employees
(September 30)

9 460

8 379

1 081